ROCHESTER, N.Y. — Bausch & Lomb, the global eye health company, announced today that it has named Flemming Ornskov, M.D., MPH, as corporate vice president and global president, Pharmaceuticals. He is responsible for the company’s prescription ophthalmic pharmaceuticals and generics, as well as its general eye health and vitamins businesses.
Most recently, Dr. Ornskov was CEO and president of LifeCycle Pharma, an emerging cardiovascular and transplantation specialty company. Prior, he served as CEO and president of biotech start-up Ikaria, Inc. From 2002 to 2005, he was president of the Ophthalmics Business Unit for Novartis, and formerly led Novartis’ U.S. cardiovascular franchise. Dr. Ornskov has also held multiple leadership positions at Merck & Co.
He serves on several boards, and is chairman of the board for Santaris Pharma A/S and Astion Pharma A/S.
Dr. Ornskov received a M.D. degree from University of Copenhagen, a M.B.A. degree from INSEAD and a Master of Public Health degree from Harvard University.
“Dr. Ornskov’s expertise in specialty and ophthalmic pharmaceuticals, plus his broad global experience developing pharmaceuticals from early stage discovery to market introduction, will help further accelerate Bausch & Lomb’s goal to create long-term value,” said Gerald M. Ostrov, Bausch & Lomb chairman and CEO. “Our pharmaceuticals business is the fastest growing component of the company, and Dr. Ornskov’s leadership will help create additional opportunities for technology commercialization and global markets penetration.”
Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Founded in 1853, the Company is headquartered in Rochester, N.Y., and employs approximately 13,000 people worldwide. Its products are available in more than 100 countries. More information about the Company can be found at www.bausch.com.